SCHEMBL13008232

SCHEMBL13008232

c1ccc2c(c1)Cc1ccccc1N2c1ccc2c(-c3ccccc3-c3ccc4ccccc4c3)c3cc(N4c5ccccc5Cc5ccccc54)ccc3c(-c3ccccc3-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.40
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
GSTP1 P09211 1/20 0.35
HPGD P15428 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
AKT1 P31749 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HTR3A P46098 1/20 0.31
GPR84 Q9NQS5 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
PRKDC P78527 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13427007 0.98 MET (0.39) METHDAC4HDAC2HDAC8GSTP1
SCHEMBL13427037 0.94 MET (0.39) METHDAC4HDAC2HDAC8GSTP1
SCHEMBL13009167 0.93 MET (0.40) METHDAC4HDAC2HDAC8GSTP1
SCHEMBL13009373 0.91 MET (0.39) METHDAC4HDAC2HDAC8GSTP1
SCHEMBL13009390 0.90 HSP90AA1 (0.36) METHDAC4HDAC2HDAC8GSTP1
SCHEMBL13008985 0.90 HSP90AA1 (0.36) METHDAC4HDAC2HDAC8GSTP1
SCHEMBL13008239 0.89 PIM1 (0.35) METHPGDALDH1A1LMNACYP1A2
SCHEMBL13009236 0.89 HSP90AA1 (0.35) METGSTP1HPGDALDH1A1LMNA
SCHEMBL13008243 0.89 MET (0.35) METHDAC4HDAC2HDAC8HPGD
SCHEMBL13540266 0.88 MET (0.33) METHPGDALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A MET 3253/4885HDAC4 3531/4885HDAC2 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.